Prosthetic Heart Valves Market, By Product Type (Transcatheter Heart Valves, Mechanical Heart Valves and Tissue Heart Valves), By End User (Hospitals and Ambulatory Surgical Centers), and Geography - Global Trends, and Forecast to 2025

  • Published On : Feb 2018 |
  • Pages : 190 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Prosthetic Heart Valves Market - Insights

Prosthetic heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where it does not provide relief to the patient, then surgery recommended as the best alternative to repair or replace the valve. In case of a valve replacement surgery, carbon based mechanical valves and biological tissue valve are the types of valves that can be selected based on the condition. On the basis of product type, the global prosthetic heart valve market can be segmented into mechanical heart valves, transcatheter heart valves, and tissue heart valves. Tissue heart valves are harvested from pig heart valves and cow heart sac. The life of a tissue valve is 10 to 15 years. Advancements in technology and increasing prevalence of heart valve diseases are some major factors projected to drive growth of the prosthetic heart valve market in the near future.

The global prosthetic heart valves market is valued at US$ 3,622.72 million in 2017 and is expected to witness a CAGR of 11.2% over the forecast period (2017 – 2025).

Figure 1. Global Prosthetic Heart Valves Market Share, by Product Type, 2017 & 2025 (%)

prosthetic heart valves market

Source: Coherent Market Insights Analysis (2017)

Growing Aging Population and prevalence of valvular disease spur growth of the prosthetic heart valve market

Increasing geriatric population and prevalence of valvular heart disease will boost the demand of prosthetic heart valves market. According to the National Centre for Health Statistics, 2011, Heart disease is the leading cause of death in the U.S., killing more than 600,000 Americans each year. Continue focusing to advance surgical replacement technologies for patients with diseased, damaged or malfunctioning heart valves by manufacturers is expected to create a lucrative opportunities for the market over the forecast period. For instance, in 2017, Edwards Lifesciences Corporation received U.S. FDA approval for aortic and mitral valve-in-valve procedures using the Edwards SAPIEN 3 transcatheter heart valve. The SAPIEN 3 valve is the first transcatheter heart valve approved in the U.S. for the treatment of both aortic and mitral patients who are at high risk for a subsequent open-heart surgery to replace their bioprosthetic valve. On the contrary, the high costs associated with the devices mainly transcatheter aortic valve replacement devices and stringent government regulations may hamper the growth of the market.

The growth of prosthetic heart valve market size in Asia is expected to be high in the near future due to increasing incidence of various chronic diseases and improving healthcare infrastructure in this region. According to a study published in the Lancet—a U.K.-based medical journal, 2016—the number of people affected by high blood pressure has almost doubled over past 40 years (from 1975 to 2015) worldwide. However, the largest rise in the prevalence of adults with high blood pressure has been in low- and middle-income countries (LMICs) in south Asia (eg, Bangladesh and Nepal) and sub-Saharan Africa (eg, Ethiopia and Malawi). Moreover, in according to EurekAlert global news, In 2015, over half (590 million) of adults with high blood pressure lived in east, southeast and south Asia--of whom 199 million lived in India and 226 million in China.

Manufacturers are focusing on developing and manufacturing new technological advanced prosthetic heart valve devices to treat heart valve and vascular disease through strategic partnership. For instance, in January, 2016, CryoLife, Inc. completed the acquisition of On-X Life Technologies Holdings, Inc, an Austin, Texas-based, privately held mechanical heart valve company, for On--X mechanical heart valves that are made with the most advanced material – pure pyrolytic carbon. This advanced design and materials creates a lucrative opportunity for the adoption of prosthetic heart valve devices in the hospitals more, which make the surgery smooth with excellent valve performance, safety, and durability. 

The key players operating in the global prosthetic heart valves market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, LivaNova PLC, Abbott, Jenavalve Technology, Inc., Lepu Medical Technology Co., Ltd., CryoLife, Inc., and Neovasc Inc.

Heart valves play an important role in controlling the blood flow to and from the heart. The heart consists of four main types of valves that are tricuspid, pulmonary, mitral, and aortic valves. Prosthetic heart valves are commonly known as artificial valves that implanted in the heart of the patients suffering from the valvular heart disease. Thus, the surging incidence of heart disorders drives the prosthetic heart valve market over the forecast period. There are 3 types of prosthetic heart valve such as mechanical heart valve, tissue heart valve, and transcatheter heart valve.

Market Dynamics

The aging population and increasing patient population of heart disease are expected to drive demand for prosthetic heart valve-based treatment in the future. For instance, According to the statistics of World Health Organization in 2012, 17.6 million people died of cardiovascular disease (CVD) worldwide, and proportionally, this accounts for 31.43% of global mortality. Moreover, The emergence of valve-in-valve procedures serves as a significant market opportunity for the prosthetic heart valve. Physicians are opting to use bioprosthetic valves because they are confident that in the case of tissue valve degeneration, they will be able to re-intervene and percutaneously implant a transcatheter valve. Given the high treatment costs associated with Transcatheter Aortic Heart Valve (TAVR), strict regulations by the government may restraint the market growth during the forecast period. However, if the cost of this technology can be reduced, as is expected with the approval of next-generation devices by manufacturers, the prosthetic heart valve will be the most lucrative market for medical device companies. For instance, in February, 2018, Medtronic Plc’s product- Mosaic bioprosthetic heart valve demonstrated positive performance and Long-Term Durability Up to 12 Years in International Study. This clinical study supports the long-term, robust performance of the Mosaic valve, and reinforces the trend in the decreasing average age of recipients.

Key features of the study:

  • This report provides in-depth analysis of prosthetic heart valves in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global prosthetic heart valves market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, LivaNova PLC, Abbott, Jenavalve Technology, Inc., Lepu Medical Technology Co., Ltd., CryoLife, Inc., and Neovasc Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
  • The global prosthetic heart valves market report caters to various stakeholders in this industry including investors, suppliers, prosthetic heart valves device manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the prosthetic heart valves market

Detailed Segmentation:

  • Global Prosthetic Heart Valves Market, By Product Type:
    • Transcatheter Heart Valves
    • Mechanical Heart Valves
    • Tissue Heart Valves
  • Global Prosthetic Heart Valves Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
  • Global Prosthetic Heart Valves Market, By Geography:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Transcatheter Heart Valves
        • Mechanical Heart Valves
        • Tissue Heart Valves
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type:
        • Transcatheter Heart Valves
        • Mechanical Heart Valves
        • Tissue Heart Valves
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
    • Asia-Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type:
        • Transcatheter Heart Valves
        • Mechanical Heart Valves
        • Tissue Heart Valves
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
      • By Product Type:
        • Transcatheter Heart Valves
        • Mechanical Heart Valves
        • Tissue Heart Valves
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Transcatheter Heart Valves
        • Mechanical Heart Valves
        • Tissue Heart Valves
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
    • Africa
      • By Country:
        • South Africa
        • North Africa
        • Central Africa
      • By Product Type:
        • Transcatheter Heart Valves
        • Mechanical Heart Valves
        • Tissue Heart Valves
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
  • Company Profiles
    • Boston Scientific Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments
      • Strategies
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • LivaNova PLC
    • Abbott
    • Jenavalve Technology, Inc.
    • Lepu Medical Technology Co., Ltd.
    • CryoLife, Inc.
    • Neovasc Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • Industry Trends
    • Technological Advancements
    • PEST Analysis
    • PORTER’S Five Forces
  4. Global Prosthetic Heart Valves Market, By Product Type, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017–2025
      • Segment Trends
    • Transcatheter Heart Valves
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Mechanical Heart Valves
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Tissue Heart Valves
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
  5. Global Prosthetic Heart Valves Market, By End User, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
  6. Global Prosthetic Heart Valves Market, By Regions, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Region, 2017–2025
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Boston Scientific Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Edwards Lifesciences Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Medtronic plc
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • LivaNova PLC
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Abbott
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Jenavalve Technology, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Lepu Medical Technology Co., Ltd.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • CryoLife, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Neovasc Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
  8. Section
    • Analyst Views
    • Research Methodology
    • About Us and Sales Contact

*Browse 29 market data tables and 33 figures on "Prosthetic Heart Valves Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.